Royce & Associates’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
|
|||||
|
2025
Q1 | $2.84M | Buy |
|
|||||
|
2024
Q4 | $3.33M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $794K | Buy |
|
|||||
|
2024
Q1 | $341K | Sell |
|
|||||
|
2023
Q4 | $1.54M | Sell |
|
|||||
|
2023
Q3 | $1.32M | Buy |
|
|||||
|
2023
Q2 | $1.83M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | $1.47M | Buy |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | $534K | Sell |
|
|||||
|
2022
Q1 | $8.7M | Sell |
|
|||||
|
2021
Q4 | $13.3M | Sell |
|
|||||
|
2021
Q3 | $17.2M | Buy |
|